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Abstract
The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazoliumbromide (MTT) reduction assay is a frequently used and easily
reproducible method to measure beta-amyloid (Ab) toxicity in different types of single cell culture. To our knowledge, the
influence of Ab on MTT reduction has never been tested in more complex tissue. Initially, we reproduced the disturbed MTT
reduction in neuron and astroglia primary cell cultures from rats as well as in the BV2 microglia cell line, utilizing four
different Ab species, namely freshly dissolved Ab (25-35), fibrillar Ab (1-40), oligomeric Ab (1-42) and oligomeric Ab (1-40). In
contrast to the findings in single cell cultures, none of these Ab species altered MTT reduction in rat organotypic
hippocampal slice cultures (OHC). Moreover, application of Ab to acutely isolated hippocampal slices from adult rats and in
vivo intracerebroventricular injection of Ab also did not influence the MTT reduction in the respective tissue. Failure of Ab
penetration into the tissue cannot explain the differences between single cells and the more complex brain tissue. Thus
electrophysiological investigations disclosed an impairment of long-term potentiation (LTP) in the CA1 region of
hippocampal slices from rat by application of oligomeric Ab (1-40), but not by freshly dissolved Ab (25-35) or fibrillar Ab (1-
40). In conclusion, the experiments revealed a glaring discrepancy between single cell cultures and complex brain tissue
regarding the effect of different Ab species on MTT reduction. Particularly, the differential effect of oligomeric versus other
Ab forms on LTP was not reflected in the MTT reduction assay. This may indicate that the Ab oligomer effect on synaptic
function reflected by LTP impairment precedes changes in formazane formation rate or that cells embedded in a more
natural environment in the tissue are less susceptible to damage by Ab, raising cautions against the consideration of single
cell MTT reduction activity as a reliable assay in Alzheimer’s drug discovery studies.
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Introduction
Deposits of beta-amyloid (Ab) and neurofibrillary tangles are the
two pathological hallmarks of Alzheimer’s disease. There is recent
evidence that soluble Ab aggregates can impair function,
morphology and subsequently the viability of neuronal cells [1].
Based on NADH dependent reduction activity, cells are able to
reduce the tetrazolium salt MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide] into a formazane [2]. Thus, it is
widely accepted that the amount of formazane production
correlates with both the number and the viability of the cells.
The MTT assay is well established for investigations of cellular
viability in single cell cultures [3] and tissue slices [4,5]. The MTT
assay is frequently used to evidence Ab related changes in
membrane properties and disturbed cellular viability [6,7]. The
question how Ab inhibits cellular MTT reduction is still a matter
of debate. Based on their findings that Ab potently inhibits cellular
reduction of MTT in cultured rat hippocampal neurons and HeLa
cell lines, Kaneko et al. (1995) have hypothesized that Ab
specifically suppresses mitochondrial succinate dehydrogenase [8].
Studies on rat brain tumor cells [9] and astrocytes [10], on the
other hand, indicated that Ab decreases cellular MTT reduction
by accelerating the exocytosis of MTT formazan.
Although many in vitro findings on Ab toxicity and competing,
protective agents are based on the MTT assay [11–14], the
influence of Ab on MTT reduction has never been tested in
more complex models than single cell cultures. Organotypic
hippocampal slices (OHC) are an in vitro model that retains the
three dimensional structure of in vivo systems and ranges in
complexity between primary cell cultures and intact animals
[15]. OHCs represent a well established tool for the investigation
of brain damage due to oxygen glucose deprivation (OGD) [16]
or epilepsy [17]. When OHCs were exposed to very high doses
of Ab ($10 mM) neuronal apoptotic cell death [18,19] and a
pronounced activation of astrocytes [20] occurred. More subtle
submicromolar Ab concentrations caused a retraction of
neuronal dendrites and a degeneration of dendritic spines [21].
Although it has been shown that MTT is appropriate to evaluate
the viability of brain tissue slices and its reduction is impaired
after detrimental treatment, such as OGD [5,22], the influence
of Ab on MTT reduction in OHCs has never been tested
before.
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for the effect of different Ab species, varying in molecule length
and aggregation status, on MTT reduction. We used freshly
dissolved Ab (25-35), which is frequently used and already shown
to exert detrimental effects on brain function and MTT
reduction of single cells well before aggregation occurs [23,24].
However, we can not exclude aggregation of Ab (25-35)
occurring during the experiment. Further, we used Ab (1-40)
fibrils, which are polypeptide aggregates, characterized by a
fibrillar structure and the presence of a cross-b conformation
[25]. These fibrils were shown to impair cellular MTT reduction
[7]. The third species tested were so-called ‘oligomers’ of Ab (1-
42) [26] and Ab (1-40) [27]. These oligomers are small non-
fibrillar aggregates that are defined by an almost spherical shape
and that have been discussed to be early mediators of cellular
malfunction within the Alzheimer afflicted brain [28]. Moreover,
we analyzed the influence of freshly dissolved Ab (25-35), fibrillar
Ab (1-40) and oligomeric Ab (1-40) on long-term potentiation
(LTP) the cellular correlate for learning and memory [29] in
acute hippocampal slices from rats and compared it with the
influence on MTT activity. Surprisingly, in all tissue cultures we
could not confirm the Ab effects on MTT reduction known from
primary cell cultures.
Results
Ab impaired MTT reduction in neuronal, astroglia and
microglia single cell cultures
We extensively investigated different Ab species, namely freshly
dissolved Ab (25-35), fibrillar Ab (1-40), oligomeric Ab (1-40) and
oligomeric Ab (1-42) for their effects on MTT reduction in
neuronal, astroglia and microglia single cell cultures, representing
the majority of cell types within the brain. In accordance with the
literature [2,10], each Ab species led to a pronounced diminution
of MTT reduction in all cell types tested (Neurons: control
10064.4%, Ab (25-35) 84.463.9%, fibrillar Ab (1-40)
61.163.5%, oligomeric Ab (1-40): 46.062.4%, Ab (1-42)
77.765.1%; Microglia: control: 10065.6%, Ab (25-35)
25.966.2%, fibrillar Ab (1-40) 42.366.5%, oligomeric Ab (1-
40): 49.162.5%, Ab (1-42) 72.763.1% Figure 1A). As we
intended to investigate the effect of Ab on MTT reduction in
OHCs, where the most abundant cell type is astroglia, we
determined the Ab effect in detail in astroglia single cell cultures.
Because OHCs and astroglial cultures are cultivated in different
culture media we elucidated whether or not the Ab mediated
disruption of MTT reduction is influenced by the culture medium.
All Ab species tested acted in a dose dependent manner and Ab
(25-35) showed the highest activity (Figure 1B). In agreement with
the literature [30], the Ab effect could be blocked by congo red
(Figure 1B). In neurobasal (NB) medium (used for OHC
cultivation) the Ab effect on MTT activity was similar to the
results obtained with DMEM (used for single cell culture; 500 nM
Ab (25-35) in DMEM: 43.763.7%, 500 nM Ab (25-35) in NB:
39.462.2%; values were normalized to control; Figure 1B).
Ab (25-35), Ab (1-40) and Ab (1-42) failed to impair MTT
reduction in OHC
Compared to single cells, the MTT reduction in OHCs was less
frequently investigated. Therefore, we characterized the MTT
assay in our system and examined its practicability to measure cell
toxicity in OHCs. Similar to single cells, OHC produced the first
formazane crystals immediately after MTT application and the
reaction was saturated within 3 hours (Figure 2A). The MTT
activity was diminished to 17.563.4% by application of 15 mM
glutamate (Figure 2B). Since this is an approved model for
excitotoxicity related cell damage [17], we considered the MTT
reduction assay to be suitable for the detection of cell damage in
OHCs.
As we intended to reproduce the Ab effect from single cells in
OHCs we applied high concentrations of freshly dissolved Ab (25-
35), fibrillar Ab (1-40), oligomeric Ab (1-40) and oligomeric Ab (1-
42). Surprisingly, no Ab species caused an effect on MTT
reduction, independent from the cell culture medium (Ab (25-35)
in NB: 93.4622.1%; in DMEM: 100.9619.1%; Figure 2B) and
the kind of application (in the medium: Ab (25-35) 93.4622.1%,
fibrillar Ab (1-40) 103.2%617.5%, oligomeric Ab (1-40)
103.4%622.6% on top of the slice Ab (25-35): 94.9%625.3%;
Ab (1-42) 106.5%619.3%); Figure 2B). Similar results were
obtained for slices that were cultivated for a longer time period (20
DIV), ruling out the possibility that older and less viable slices are
more susceptible to Ab (aged OHCs: Ab (25-35) 96.7624.1%, Ab
(1-40) 96.6%634.5%; Figure 2B).
Succinate dehydrogenase activity [31] and exocytotic process-
es [32] are temperature-dependent and exocytosis is influenced
by osmotic forces [33]. In order to exclude that temperature and
osmolarity modify the Ab effect on MTT reduction in OHCs,
we scrutinized the effect of these two parameters. However,
lowering the ambient temperature to 21uCo r4 uC generally
caused a decreased MTT reduction activity of the slices
(absolute values not shown), but did not elicit an Ab-induced
diminution in MTT reduction. In addition, the MTT reduction
under hypotonic (280 mosmol*kg
21-causes a cell swelling) and
hypertonic (330 mosmol*kg
21-causes a cell shrinkage) conditions
was also not significantly altered (Ab (25-35) hypertone medium
112.9%615.6%, Ab (25-35) hypotone medium 107.3%612.4%
of control; Figure 2B). Additionally, we confirmed the missing
toxic effect of freshly dissolved Ab (25-35) and fibrillar Ab (1-40)
in OHCs by an unchanged PI staining and by measuring the
release of cytosolic enzyme lactate dehydrogenase (LDH) into
the culture supernatant. There was no differences in the PI
staining (Figure 2C) and the LDH release of Ab (25-35) and
fibrillar Ab (1-40) treated slices, compared to control (LDH data
not shown).
In order to rule out that diffusion problems due to the size of the
Ab aggregates impede toxicity in the OHCs, we immunostained
cross sections of OHCs after Ab (1-40) treatment. Ab was clearly
marked within the slice (Figure 2D). Furthermore and in line with
the literature [20,34], Ab (1-42) caused an activation of astroglia,
as demonstrated by an increased expression of GFAP (Figure 2E).
These results indicate that Ab was able to affect the astroglia
within the OHC, although Ab failed to disturb the MTT
reduction of the slice.
Separation of single cells from OHCs and treatment with
Ab
Considering our conflicting findings in single cells and OHCs it
appeared likely that the susceptibility of cells to Ab mediated
diminution of MTT reduction activity depends on their
environment. To address this matter, we split one OHC
preparation into two groups. One group was cultivated further
and the other group was separated into single cells. For the first
time we prepared single cells from OHCs. Because of the
matured state of the isolated cells only few neurons survived the
isolation procedure and thus the cultures consisted largely of
astrocytes (Figure 3).
When we exposed the slices to Ab (25-35) before the
separation and measured the MTT reduction activity two hours
after the preparation, there was no effect of Ab (25-35) on the
Ab-MTT-Effect in Brain Slices
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(Figure 3A). In contrast, when the slices were first separated
and then Ab (25-35) was applied to the two groups for 2 days,
Ab diminished the MTT reduction in single cell cultures but
not in OHCs (Ab (25-35) 80.1%61.0% control: 100%61,1%;
Figure 3B).
Figure 1. Influence of Ab on MTT reduction of single cell cultures. A) Influence of Ab on MTT reduction of neuron and microglia single cell
cultures. When applied to cell cultures for 3 days, at 1 mM all Ab species diminished the MTT reduction significantly in both cell types. The dashed line
indicates the control level; *=p#0.05, Mann–Whitney U-test, n=10 per group B) Concentration dependent influence of Ab on MTT reduction activity
of astroglia single cell culture. When applied to cell culture for 3 days, any Ab species diminished the MTT reduction significantly, compared to
control. Congo red (2 mM) completely reverses the Ab effect; Ab (25-35) diminished the MTT reduction in NB medium, normally used for cultivation of
OHC; the dashed line indicates the control level; *=p#0.05, Mann–Whitney U-test, n=10 per group C) Electron microscopic images (EMI) revealed
that freshly dissolved Ab (25-35) did not form aggregates. Moreover, EMI conformed the needle like structure of fibrillar Ab (1-40) and the smaller,
spherical shape of oligomeric Ab (1-40) and oligomeric Ab (1-42).
doi:10.1371/journal.pone.0003236.g001
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Ab species and does not correlate with MTT reduction in
acute hippocampal slices
To further substantiate the assumption that cells within tissue-
like structures react different to Ab than single cells, we exposed
acutely isolated hippocampal slices from adult rats to 500 nM Ab
(25-35) or 500 nM oligomeric Ab (1-40) or 1 mM fibrillar Ab (1-
40) and measured the influence on LTP. When we exposed slices
to Ab (25-35) and oligomeric Ab (1-40), 30 min before tetanus
application, Ab (25-35) did not influence the LTP, while
application of oligomeric Ab (1-40) significantly attenuated LTP
(oligomeric Ab (1-40): 139.5%611.3% n=8; Ab (25-35):
184.2%615.8% n=8; control: 189.7%615.9% n=16 of baseline
value 240 min after tetanus application; Figure 4A). Because of
their large molecule size Ab (1-40) fibrils were expected to have
limited and slow access to neuronal target structures. Therefore,
we exposed slices to Ab (1-40) fibrils persistently throughout the
experiment and with a relatively high concentration of 1 mM.
However, application of fibrillar Ab (1-40) did not alter LTP
(fibrillar Ab (1-40): 187.1616.6%, n=8, of baseline value,
240 min after tetanus application; Figure 4A). To investigate
whether the disturbed LTP caused by Ab (1-40) oligomers
correlates with a diminished MTT reduction, we applied MTT
to acute slices in parallel to LTP recording. There was no
difference in the MTT reduction between control, Ab (25-35) and
Ab (1-40) oligomer treated slices (ACSF control: 100.0625.0%,
Ab (1-40) 107.9%627.0%; Ab (25-35) 106.7%615.7% Figure 4B).
Ab failed to diminish MTT reduction in vivo
The short life span of acutely isolated slices from adult animals
limits the exposure to Ab aggregates. OHCs in contrast, allow
long-time Ab exposure but constitute of juvenile tissue. As we
could not exclude that longer Ab applications would indeed be
able to reduce cellular viability in mature tissue we injected Ab
(25-35) and oligomeric Ab (1-42) into the rat brain. Three days
after Ab application, the animals were sacrificed and we measured
the MTT reduction in freshly prepared hippocampal slices. Ab
(25-35) and Ab (1-42) did not influence the MTT reduction in this
in vivo/ex vivo approach (untreated animal: 103.4623.7%, Ab (35-
25) control: 100.0%626.2%, Ab (1-42) 99.4%614.9%; Ab (25-
35) 108.0%620.4%; Figure 4C). To prove whether injected Ab
diffused into the hippocampus, we immunostained cross sections of
the ex vivo slices. Ab (1-42) oligomers were clearly marked within
the slice (Figure 4D). Hence, an effect of Ab on hippocampal cells
could be expected. However, we could not observe a staining of
Ab (25-35), probably due to a wash out of that protein during the
Figure 2. Influence of Ab on MTT reduction, PI uptake and GFAP expression of OHC. A) Time dependent MTT reduction activity of OHC.
Numbers indicate the time after MTT application in minutes B) Influence of glutamate, freshly dissolved Ab (25-35), fibrillar Ab (1-40) and oligomeric
Ab (1-42) on MTT reduction activity of OHC under different conditions. Application of 10 mMA b for 3–6 days did not diminish the MTT reduction of
OHC under different conditions; application of glutamate (15 mM) significantly reduced the MTT reduction, compared to control; the dashed line
indicates the control level; *=p#0.05, Mann–Whitney U-test, n$12 per group C) PI staining of Ab and glutamate treated OHCs. Application of 10 mM
freshly dissolved Ab (25-35) and 10 mM fibrillar Ab (1-40) into the medium for 3 days did not cause cell death. Application of glutamate (15 mM)
induced cell death D) Immunostaining of cross sections against fibrillar Ab (1-40) revealed the presence of Ab in the slice E) GFAP and DAPI staining of
oligomeric Ab (1-42) treated and control slice. Ab (1-42) caused an activation of astroglia within the OHC, indicated by an increased GFAP expression.
doi:10.1371/journal.pone.0003236.g002
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diffuse into the hippocampus, a successful diffusion of the smaller
Ab (25-35) peptide is likely. These data indicate that the missing
Ab effect on MTT reduction in OHC and acute isolated
hippocampal slices represent the in vivo situation.
Discussion
In this study we compared the effect of different Ab species on
the MTT reduction activity in hippocampal neurons, astrocytes,
microglia, OHCs, acutely isolated hippocampal slices from adult
animals and the hippocampal formation in vivo. We showed that all
tested Ab species impaired MTT reduction activity in all single cell
cultures already at high nanomolar concentrations. These findings
are in good agreement with various other studies investigating
toxic or activating Ab effects in hippocampal neurons [35],
astrocytes [10] and microglia [36]. In contrast to our findings in
the single cell cultures none of the Ab species affected cellular
viability in OHCs, although we could confirm the presence of Ab
in the slices by immunostaining and GFAP upregulation. In line
with our observations other studies in OHCs also showed no or, at
very high concentrations, only very limited toxic effects of Ab (25-
35), Ab (1-40) and Ab (1-42) [18,19,37,38]. In contrast to that and
to our findings Lambert et al. published in 1998 that slice cultures
could be injured with as little as 5 nM soluble Ab (1-42) of so
called Ab derived diffusible ligands (ADDL) [39]. Later, Chong et
al. described in 2006 neuronal cell death in hippocampal brain
slices because of Ab (1-42) oligomer treatment [40]. The reason for
the difference to our results could be the kind of Ab (1-42)
preparation, as both groups used aggregation protocols which
resulted in spheres of approximately similar size. However, their
contrasting observations render it likely that their mode of
preparation resulted in a different internal structure of the
aggregates. Future studies should be carried out to extensively
compare the different Ab species for their potentially different
effects. Nevertheless, we observed comparable detrimental effects
of all investigated Ab species on MTT reduction in single cell
culture, which could not be seen in any complex tissue. That
discrepancy between single cells and OHCs regarding the effect of
Ab is difficult to reconcile. As single cell cultures are almost
exclusively prepared from embryonic tissue and as OHCs
represent juvenile tissue one explanation could be that the
respective cells are in different physiological states. Scrutinizing
this assumption we show that single cells obtained from juvenile
OHCs are only susceptible to Ab effects after being cultured.
Similarly, Yankner et al. (1990) reported that dissociated neurons
maintained in cultures are resistant to Ab (25-35) toxicity during
the first days in culture and that Ab neurotoxicity increases with
the age of the culture [41]. This may indicate that cultured cells
and cells that are embedded in the intact hippocampal synaptic
Figure 3. Influence of Ab on MTT reduction activity of OHC and single cells, generated from OHC. A) Ab (25-35) 1 mM was applied to the
slice for 3 days. The MTT assay was done 2 hours after the preparation of the single cells out of the slice. In this case, 1 mMA b did not diminish the
MTT reduction of OHC and single cells; B) 1 mMA b was applied to the slices and single cells after the preparation for 2 days. In this case, Ab (25-35)
1 mM significantly reduced the MTT reduction of single cells, compared to control; *=p#0.05, Mann–Whitney U-test, n=10 per group.
doi:10.1371/journal.pone.0003236.g003
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crucial for Ab toxicity or that the interaction between the neural
elements in the relatively intact tissue enables a counteracting
protective mechanism. Possible mechanisms may be alterations in
the membrane lipid composition [42] or an altered accessibility of
lipid rafts for Ab [43]. Similar reasons may account for the Ab
effects in studies where OHCs were cultured for several weeks
[44]. These findings do not reflect the situation in adult tissue as
we and others [45] did not observe a fast toxic effect of Ab after in
vivo application. Also consistent with our results Geula et al. (1998)
did not observe a significant Ab toxicity in aged rats but found
age-dependent Ab toxicity in aged monkeys [46]. This does not
Figure 4. Influence of Ab on LTP and MTT reduction of acute isolated slices. A) Influence of freshly dissolved Ab (25-35), oligomeric Ab (1-
40) and fibrillar Ab (1-40) on LTP of acute hippocampal slices. Oligomeric Ab (1-40) significantly reduced the LTP, compared to control potentiation.
Freshly dissolved Ab (25-35) and fibrillar Ab (1-40) did not effect the LTP; *=p#0.05 ANOVA with repeated measures; The bar indicates the time of Ab
application. Tetanus was applied at time point 0; Analogue traces represent typical recordings of single experiments taken 20 minutes before
tetanization (1), and 240 minutes after tetanization (2). B) Ab treated acute slices did not differ from control slices in their MTT reduction activity. C)
Influence of Ab on MTT reduction activity of ex vivo slices. Injection of freshly dissolved Ab (25-35) and oligomeric Ab (1-42) for 3 days did not
diminish the MTT reduction of the ex vivo slices, compared to untreated animals and the reverse control protein Ab (35-25). D) Immunostaining of
cross sections against Ab revealed the presence of oligomeric Ab (1-42) in the hippocampus.
doi:10.1371/journal.pone.0003236.g004
Ab-MTT-Effect in Brain Slices
PLoS ONE | www.plosone.org 6 September 2008 | Volume 3 | Issue 9 | e3236exclude that the hippocampal neurons in OHCs, acutely isolated
slices and in vivo are physiologically impaired, as LTP was
disturbed in the acutely isolated slice preparations at least after Ab
oligomer application. Recent studies increasingly indicated that
soluble, pre-fibrillar Ab assemblies rather than mature fibrils may
induce early neuronal alterations, leading to physiological
interruption before cell death is detectable [47]. Our LTP
experiments elucidated the effects of distinct Ab species on
synaptic potentiation. We show that Ab (1-40) oligomers disturbed
LTP, whereas Ab (1-40) fibrils did not impair LTP, although Ab
(1-40) fibrils where higher concentrated and permanently exposed
to the slices. This is in good agreement with the current view that
Ab oligomers are responsible for the early disturbance of brain
physiology [48–51]. Whether or not LTP disturbances are a first
sign of neuronal degeneration remains to be elucidated. If so, the
MTT assay would evidently be unable to detect such early
alterations in cellular physiology, as we demonstrated that Ab (1-
40) oligomer mediated LTP disruption was not reflected by MTT
reduction in slices. On the other hand, studies utilizing primary
neuronal and astroglial cultures showed an inhibition of MTT
reduction already 2 h after Ab application [10,52]. This may not
necessarily reflect cell death, as Ab-induced alterations in MTT
reduction in human cortical cultures could not be confirmed with
other cytotoxicity assays like LDH and alamarBlue [53].
Ab (25-35) did not affect LTP in the present study, although a
diminution in LTP was found by others [54]. One possible
explanation for this discrepancy is the strain dependence of the Ab
(25-35) effect, as Gengler (2007) showed that the influence of Ab
(25-35) on LTP in rat depends on their genetic background [55].
Taken together, we showed that single cell cultures are prone to
impairment by Ab, whereas cells embedded in the intact
hippocampal synaptic circuitry and anatomy are quite resistant,
suggesting that results obtained with cell cultures cannot be
conferred directly to complex tissue. In addition, we demonstrated
that Ab mediated LTP disruption depends on the Ab species and
does not correlate with MTT reduction in acute isolated slices,
relativizing the MTT assay as a reporter of early physiological
disruption and drug testing. Thus, Ab effects observed in single cell
cultures should be interpreted cautiously regarding their relevance
for more complex brain tissue, independently whether MTT
reflects cellular viability or precedes cell death.
Methods
Single cell culture
The animals were maintained under constant environmental
conditions, with an ambient temperature of 2162uC, a relative
humidity of 40%, a 12-h light–dark cycle and free access to food
and water. All animal procedures have been approved by the
ethics committee of the German federal state of Sachsen-Anhalt,
and are in accordance with the European Communities Council
Directive (86/609/EEC).
Cells cultures from 1-day-old Wistar rats (Institute breeding
stock) were prepared and cultured as described previously [56].
Briefly, newborn rats were decapitated, and the brains were
removed and collected in ice-cold Hanks-buffer solution (Bio-
chrom; Berlin, Germany). The brains were gently passed through
nylon meshes of 250 mm and 136 mm pore width, in consecutive
order. The cell suspension was centrifuged at 4uC for 5 min at
500g. The cells were resuspended in 10 ml growth medium
(DMEM supplemented with 10% (v*v
21) fetal calf serum,
20 U*ml
21 penicillin and 20 mg*ml
21 streptomycin).
Single cells from OHCs were isolated by gently removing the
slices from the membrane and collecting them in ice-cold Hanks-
buffer solution (Biochrom; Berlin, Germany). Then the protocol for
cell culture preparation described above was applied. Preparation
and cultivation of OHCs was done as described below.
For astrocyte-enriched cultures (95% astrocytes), cells were
seeded in 48 well plates at a starting density of 2*10
4 cells/ml in
DMEM supplemented with 10% (v*v
21) fetal calf serum and
incubated at 37uC in an atmosphere containing 5% CO2. The
medium was changed every second day. For neuron-enriched
culture (80% neurones), the DMEM was exchanged by Start V
Medium (Biochrom) 24 h after seeding.
The cell lineage BV2 microglia was cultured in DMEM
supplemented with 10% FBS, 1% Pen/Strep (Biochrom), 1% l-
Glutamin (Biochrom) at a density not exceeding 5*10
5 cells*ml
21
and maintained in 5% CO2 at 37uC.
Ab application/MTT assay
Ab (25-35) (Bachem) was freshly dissolved in bidistilled water to
a concentration of 1 mg*ml
21. For fibril formation, recombinant
Ab (1-40) [57] was dissolved in bidistilled water to a concentration
of 1 mg*ml
21 and incubated for 5–7 days at 37uC. The formation
of fibrils was verified by negative stain electron microscopy. Ab (1-
42) oligomers were generated as described [26]. The quality of the
oligomer preparation was controlled by negative stain electron
microscopy and Sodiumdodecylsulfate-Polyacrylamidgelelectro-
phoresis (SDS-PAGE). The Ab species were added to the cell
culture medium at a concentration of 0.5–10 mM( A b (1-42)
oligomers) or 0.5–20 mM( A b (1-40) fibrils) and incubated for 1–3
days. Then MTT (Carl Roth) was added to the medium
(0.5 mg*ml
21) and incubated for 3 hours. The medium was
removed and the cells were diluted in 20% SDS/50% Dimethyl-
formamid. The relative formazane concentration was measured by
determination of the absorbance at 570 nm (well plate reader,
Optima FluoStar).
Organotypic cultures
Organotypichippocampal interface slice culturesfrom10-day-old
Wistar rats (Institute breeding stock) were prepared and cultured as
interface slices as described previously [59]. Briefly, the slices were
placed on membrane inserts in 6-well plates (NUNC, Wiesbaden,
Germany) containing 1.2 ml of NB medium/well and were
maintained in a humidified incubator for 12–15 days in vitro (DIV).
Immunhistochemistry
For the immunohistochemical staining of Ab and GFAP, the
slices were fixed in 0.1 M phosphate buffer containing 4%
paraformaldehyde. The slices were stored in the fixative overnight.
After cryoprotection in 30% sucrose, the slices were rapidly frozen
in methylbutane at 280uC. The whole slices were cut on a sliding
microtome and the 20 mm sections were stored at 4uCi n
cryoprotectant (CPS) containing 25% ethylene glycol, 25%
glycerine in 0.1 M phosphate-buffered saline (PBS). The slices
were transferred from CPS to 0.1 M phosphate buffer and washed
overnight. Unspecific bindings were blocked for 2 h in the
corresponding serum and then the slices were incubated with
the primary antibodies and stored at 4uC overnight. All secondary
antibodies were incubated at room temperature for 2 h. The slices
were then coverslipped with 1,3-diethyl-8-phenylxanthine (DPX).
The following primary antibodies and final dilutions were used:
monoclonal mouse anti-GFAP (1:200; Chemicon), polyclonal
chicken anti-Ab (1:500; abcam), DAPI (1:10000; MoBiTec). The
primary antibodies were diluted in 0.1 M PBS/0.5% Triton X-
100 and 3% donkey normal serum (Sigma, Deisenhofen,
Germany). The following secondary antibodies and final dilutions
were used: donkey anti-mouse Cy3 (1:500; Dianova), donkey anti-
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diluted in 0.1 M PBS.
Ab application/MTT assay/PI staining
The Ab species were added to the slice culture medium at the
respective concentrations (1–10 mM) and incubated for 3–6 days.
For the application ‘‘on top of the slice’’, 1 ml of the Ab stock
solution was directly applicated onto the surface of the slice. 1 mlo f
the solvent was applicated onto the control slices. Then MTT was
applied to the medium (0,5 mg*ml
21) and incubated for 3 hours.
The slices were quickly removed from the membrane and
completely diluted in 20% SDS/50% dimethylformamid (incuba-
tion for 24 h at RT). After centrifugation, the relative formazane
concentration of the supernatant was measured by determination
of the absorbance at 570 nm (well plate reader, Optima FluoStar).
Electron microscopy was done as previously described by [60].
Cell death was evaluated by cellular incorporation of propidium
iodide (PI) 3d and 6d after Ab treatment. Cultures were incubated
with PI-containing medium (10 mM) for 2 h at 33uC. Fluorescent
images were acquired semiautomatized (Nikon motorized stage;
LUCIA software) and analyzed by densitometry to quantify
necrotic cell death (LUCIA Image analysis software).
Acute hippocampal slices/LTP
Hippocampal slices (400 mm thick) were prepared from 7- to 8-
week-old male Wistar rats (Institute breeding stock) as described
previously [61]. Briefly, both hippocampi were isolated and
transferred into a submerged-type recording chamber where they
were allowed to recover for at least 1 h before the experiment
started. The chamber was constantly perfused with artificial
cerebrospinal fluid (ACSF) at a rate of 2.5 ml/min at 3361uC.
Synaptic responses were elicited by stimulation of the Schaffer
collateral–commissural fibers in the stratum radiatum of the CA1
region using lacquer-coated stainless steel stimulating electrodes.
Glass electrodes (filled with ACSF, 1–4 MV) were placed in the
apical dendritic layer to record field excitatory postsynaptic
potentials (fEPSPs). The initial slope of the fEPSP was used as a
measure of this potential. The stimulus strength of the test pulses
was adjusted to 30% of the EPSP maximum. During baseline
recording, single stimuli were applied every minute (0,0166 Hz)
and were averaged every 5 min. Once a stable baseline had been
established, long-term potentiation was induced by applying 100
pulses at an interval of 10 ms and a width of the single pulses of
0.2 ms (strong tetanus) three times at 10 min intervals.
Ab (1-40) oligomers and fibrils were prepared as described
previously [27] and visualized by negative stain electron
microscopy. Immediately after the slice preparation, fibrillar Ab
(1-40) was persistently applied to the slices at a concentration of
1 mM. Ab (1-40) oligomers and Ab (25-35) were applied to the
slice for 30 min before tetanus application at a concentration of
500 nM. The Ab (1-40) solvent HFIP was removed from the
ACSF by exposure to a gentle stream of carbogen for 1h. For
control experiments we added the same amount of HFIP used for
the Ab (1-40) experiment to the ACSF and removed it by
gasification. There was no difference between the potentiation in
the HFIP-deprived ACSF and pure ACSF and, therefore, these
experiments were pooled. In parallel to the experiments, some
slices of the same preparation were separately exposed to Ab for
3–4 hours and analyzed with MTT assay as described above.
In vivo infusion of Ab
In vivo infusion was performed as described previously [62].
Briefly, anaesthesia of 10-week-old male Wistar rats (Institute
breeding stock) was induced with halothane in a mixture of nitrous
oxide and oxygen (50:50) and maintained with 2–3% halothane
(Sigma, Deisenhofen, Germany) via a rat anaesthetic mask
(Sto ¨lting). The animals were placed in a Kopf stereotaxic frame.
Following a midline incision, a burr hole (1 mm in diameter) was
drilled into the skull (coordinates: posterior, 0.9 mm from bregma;
lateral, 1.7 mm to satura sagittalis) and a 29-gauge cannula was
lowered to 4.5 mm below the skull, according to the rat brain atlas
of Paxinos and Watson [63]. Ab (25-35) (1 mg*ml
21)o rA b (1-42)
oligomer (1 mg*ml
21) was injected intracerebroventricularly in 3-
ml sterile solvent over 5 min. After 5 min the cannula was slowly
withdrawn. Ab (35-25) (1 mg*ml
21) was used as inactive peptide
control. After three days, acute hippocampal slices were prepared
as described above, then directly placed on cell culture membranes
and the MTT reduction activity analyzed as described above.
Statistics
Values of LTP recording are given as mean6S.E.M. Values of
MTT reduction are given as mean6S.D. As indicated in Results,
the Mann–Whitney U-test or the analysis of variance (ANOVA)
with repeated measures was used to compare the field potentials
between two groups of differentially treated cells or slices,
respectively (i.e., control vs. Ab treatment), where appropriate.
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